Procurement Summary
Country : Germany
Summary : Contract notice: Pharmaceutical products
Deadline : 10 Dec 2020
Other Information
Notice Type : Tender
TOT Ref.No.: 38147131
Document Ref. No. : 546452-2019
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : GWQ SERVICEPLUS AG
Office Name: GWQ ServicePlus AG
Address: GWQ ServicePlus AG, Tersteegenstraße 28, 40474 Düsseldorf, handelnd für die unter VI 2.) näher genannten Gesetzlichen Krankenkassen
Town: Düsseldorf
Postal Code: 40474
Phone: +49 211758498-0
Fax: +49 211758498-48
Germany
Email :bieteranfrage@gwq-serviceplus.de
URL :http://www.gwq-serviceplus.de
Tender Details
Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000
CPV Description: Pharmaceutical products.
Conclusion of a non-exclusive discount agreement according to - 130a Abs. 8 SGB V on finished medicinal products (here: Diclofenac ATR; ATC S01BC03)
- 130a Abs. 8 SGB V allows the health insurance (KK) and pharmaceutical companies, framework discounts exclude the medicinal products to be released at the expense of the statutory KK.
GWQ ServicePlus AG intends to provide non-exclUsual discount agreements according to - 130a Abs. 8 SGB V on the o. a. To close active ingredient with contract start on 1.1.2020. This contract can at any time of the contract period all interested companies to join the same conditions (approval model). The GWQ assumes that this procedure is due to a lack of selection decision and thus the non-discriminatory Zof all pharmaceutical companies does not fall within the scope of antitrust law. The contract documents, the participating health insurance companies and their sales as well as the dates for the notification of the contract can be viewed and downloaded on the allocation portal of GWQ ServicePlus AG under http://vergabeportal.gwq-serviceplus.de. Until the start of the exclusive contractThis transitional agreement is open to all market participants for accession.
Upon receipt of the signed contract / declarations and evidence as of 10.12.2019, a first notification can be made by 1.1.2020.
The following documents must be submitted: - signed contract in duplicate,
- Proof of the drug approval by means of an excerpt from the o- Part of the AMIS database,
- signed self-declaration (Annex 3),
- PZN list (Annex 4).
GWQ acts on behalf of the following statutory health insurances:
Atlas BKK ahlmann
Audi BKK
BAHN-BKK
Bertelsmann BKK
Health Insurance Fund of MTU Friedrichshafen GmbH
Health Insurance Company Herford Minden Ravensberg
BKK Aesculap
BKK Akzo Nobel Bavaria
BKK BPW Bergische Axis KG
BKK Deutsche BAnk AG
BKK Diakonia
BKK_DuerkoppEnerger
BKK Faber-Castell & Partner
Company Health Insurance Company firmus
BKK Freudenberg
BKK Groz-Beckert
BKK KBA
Krones BKK
BKK Black Forest Baar Heuberg
BKK Voralb Heller * Index * Leuze
BMW BKK
Daimler BKK
THE BERGISCHE KRANKENKASSE
The Schwenninger Health Insurance
Home Health Insurance
HEK - Hanseatic Health Insurance
IKK Brandenburg and Berlin
IKK healthy plus
IKK North
IKK Suedwest
MERCK BKK
Salus BKK
SBK Siemens Company Health Insurance Fund
SECURVITA BKK
SKD BKK
Suedzucker BKK
Wieland BKK
Internet address (URL): http://www.gwq-serviceplus.de
Documents
Tender Notice